Regenerex Pharma (RGPX) Non-Current Assets (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Non-Current Assets data on file, last reported at $569335.0 in Q3 2025.

• Non-Current Assets for Q3 2025 came in at $569335.0, down 9.79% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.4 million (down 19.18% YoY), and the FY2025 annual result was $609861.0, down 20.15% from the prior year.
• Non-Current Assets was little changed at $569335.0 in Q3 2025 per RGPX's latest filing, from $570693.0 in the prior quarter.
• Over five years, Non-Current Assets peaked at $948550.0 in Q2 2023 and troughed at $1858.0 in Q2 2021.
• A 5-year average of $382770.1 and a median of $569335.0 in 2025 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2021 and 2023: Non-Current Assets plunged 66.43% in 2021, then surged 16116.51% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $8626.0 in 2021, then retreated by 27.82% to $6226.0 in 2022, then soared by 13437.79% to $842863.0 in 2023, then retreated by 23.37% to $645872.0 in 2024, then slipped by 11.85% to $569335.0 in 2025.
• Business Quant data shows RGPX's Non-Current Assets at $569335.0 in Q3 2025, $570693.0 in Q2 2025, and $609861.0 in Q1 2025.